uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Opatanol
Authorised
Human
Details
EMA number
EMEA/H/C/000407
ATC code
S01GX09
Authorisation
16 May 2002
Revision
26
EMA page
Therapeutic indication
Treatment of ocular signs and symptoms of seasonal allergic conjunctivitis.
MeSH:
Conjunctivitis, Allergic
Group:
Ophthalmologicals
Active substances
olopatadine hydrochloride
Marketing Authorisation Holder
Novartis Europharm Limited
MAH
Timeline
Filter by authority:
EMA
Opatanol authorised
16 May 2002
authorised
regulatory
Opatanol | uMedical